PAISLEY, U.K. – Life Technologies Corporation (NASDAQ: LIFE) today announced that the company has led a successful consortium bid for a Technology Strategy Board grant, in partnership with the Oxford NIHR Biomedical Research Centre, AstraZeneca, and Ortho Biotech Oncology Research & Development unit of Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (ORD). The grant […]
AUSTIN, Texas – Luminex Corporation (NASDAQ: LMNX) today announced a definitive agreement to acquire privately-held EraGen Biosciences, Inc., an innovator in molecular diagnostic testing technologies for infectious disease and genetic applications. Under the terms of the agreement Luminex will purchase all outstanding shares of EraGen for approximately $34 million in cash, subject to certain adjustments. […]
London, UK and Ann Arbor, Michigan, US – NextGen Group plc (AIM:NGG) is pleased to announce that its US-subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has launched its first cerebrospinal fluid (CSF) multiple protein (multiplex) assay, csfdiscovery43, for central nervous system (CNS) biomarker discovery and qualification. The assay simultaneously measures […]
TUCSON, Ariz. – HTG Molecular Diagnostics, provider of molecular technology solutions, today announced the appointment of Debra Gordon, Ph.D., J.D., to Vice President, Chief Legal Counsel. This announcement comes on the heels of HTG announcing SR One, the corporate venture capital arm of GlaxoSmithKline, joined the company’s investment syndicate. Dr. Gordon will guide the development […]
PORTAGE, Mich. – Phadia, the global leader in allergy and autoimmunity diagnostics, today announced the FDA clearance of recombinant ImmunoCAP® Allergen Components for marketing in the United States. The FDA clearance applies to all of Phadia’s instrument platforms. Phadia was the first diagnostics company to introduce allergen component testing globally and the company will continue […]
VEDBAEK, Denmark – Exiqon A/S (Copenhagen:EXQ), today announced that it has granted a non-exclusive license to IDEXX Laboratories, Inc, to use Exiqon’s proprietary LNA(TM) technology in defined products for veterinary disease diagnostics. Exiqon will receive upfront and milestones payments, and royalty on global sales of the products covered by this agreement. Financial terms of the […]
VICTORIA, Australia – Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE), through its North American division, Phenogen Sciences Inc., has launched the new BREVAGen™ genetic test for assessing non-familial breast cancer risk. Phenogen Sciences will target its promotion campaign on women’s health clinics in over 20 US metro-markets. The company has deployed its sales force to […]
OMAHA, Neb. – Transgenomic, Inc. (OTC/BB: TBIO) today announced the launch of the Nuclear Mitome Test, a genetic test to aid physicians in the diagnosis of mitochondrial disorders. The Nuclear Mitome Test, employs next-generation sequencing technology to identify mutations in more than 400 genes, and represents the most comprehensive genetic test available for mitochondrial disorders. […]
SAN DIEGO – Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the appointment of Charles P. Slacik to its board of directors, effective June 15, 2011. Mr. Slacik has served as chief financial officer and senior vice president of Finance for Beckman Coulter since October 2006. He is […]
VENLO, The Netherlands – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) has made an offer and entered into exclusive negotiations to purchase a 47% initial stake in Ipsogen S.A. (Alternext: ALIPS) and subsequently make a public offer to fully acquire a global leader in molecular profiling and personalized healthcare diagnostics for a broad range […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
